Trulieve Cannabis Corp (TCNNF)
6.80
+0.23
(+3.50%)
USD |
OTCM |
Nov 15, 16:00
Trulieve Cannabis Max Drawdown (5Y): 93.46% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 93.46% |
| September 30, 2024 | 93.46% |
| August 31, 2024 | 93.46% |
| July 31, 2024 | 93.46% |
| June 30, 2024 | 93.46% |
| May 31, 2024 | 93.46% |
| April 30, 2024 | 93.46% |
| March 31, 2024 | 93.46% |
| February 29, 2024 | 93.46% |
| January 31, 2024 | 93.46% |
| December 31, 2023 | 93.46% |
| November 30, 2023 | 93.46% |
| October 31, 2023 | 93.46% |
| September 30, 2023 | 93.46% |
| August 31, 2023 | 93.46% |
| July 31, 2023 | 92.67% |
| June 30, 2023 | 92.67% |
| May 31, 2023 | 92.02% |
| April 30, 2023 | 90.58% |
| March 31, 2023 | 89.41% |
| February 28, 2023 | 88.54% |
| January 31, 2023 | 88.18% |
| December 31, 2022 | 87.44% |
| November 30, 2022 | 83.90% |
| October 31, 2022 | 83.90% |
| Date | Value |
|---|---|
| September 30, 2022 | 83.90% |
| August 31, 2022 | 78.65% |
| July 31, 2022 | 78.65% |
| June 30, 2022 | 78.19% |
| May 31, 2022 | 74.23% |
| April 30, 2022 | 72.69% |
| March 31, 2022 | 67.60% |
| February 28, 2022 | 65.26% |
| January 31, 2022 | 65.26% |
| December 31, 2021 | 65.26% |
| November 30, 2021 | 65.26% |
| October 31, 2021 | 65.26% |
| September 30, 2021 | 65.26% |
| August 31, 2021 | 65.26% |
| July 31, 2021 | 65.26% |
| June 30, 2021 | 65.26% |
| May 31, 2021 | 65.26% |
| April 30, 2021 | 65.26% |
| March 31, 2021 | 65.26% |
| February 28, 2021 | 65.26% |
| January 31, 2021 | 65.26% |
| December 31, 2020 | 65.26% |
| November 30, 2020 | 65.26% |
| October 31, 2020 | 65.26% |
| September 30, 2020 | 65.26% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
59.58%
Minimum
Nov 2019
93.46%
Maximum
Aug 2023
77.16%
Average
73.46%
Median
Max Drawdown (5Y) Benchmarks
| Bruker Corp | 46.31% |
| Karyopharm Therapeutics Inc | 97.56% |
| Apellis Pharmaceuticals Inc | 74.65% |
| cbdMD Inc | 99.85% |
| Flora Growth Corp | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -20.38 |
| Beta (5Y) | 1.585 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 77.53% |
| Historical Sharpe Ratio (5Y) | 0.0011 |
| Historical Sortino (5Y) | 0.0023 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.07% |